Expressiveness of global coagulation parameters in dilutional coagulopathy

British Journal of Anaesthesia

Volumn 105, Issue 4, 2010, Pages 429-436

  Weiss, G ^a   Lison, S ^a   Spannagl, M ^a   Heindl, B ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

clotting factors; coagulopathy; global coagulation tests; haemostasis

Indexed keywords

HETASTARCH DERIVATIVE; SODIUM CHLORIDE;

ADULT; BLOOD COAGULATION DISORDERS; FEMALE; HEMODILUTION; HEMOSTASIS; HUMAN; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOELASTOGRAPHY;

ADULT; BLOOD COAGULATION DISORDERS; FEMALE; HEMODILUTION; HEMOSTASIS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SODIUM CHLORIDE; THROMBELASTOGRAPHY;

EID: 77956922945     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq199     Document Type: Article

References (35)

1. American Society of Anesthesiologists. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208
2. Hardy J, de Moerloose P, Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004; 51: 293-310 (Pubitemid 38701939)
3. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748-754
4. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations and therapeutic considerations. J Trauma 2006; 60: S3-11
5. Ho MHA, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 2005; 190: 479-484
6. German Medical Association. Cross-sectional Guidelines for Therapy with Blood Components and Plasma Derivates, 4th Rev. Edn. Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board, 2009. Available from http://www.baek.de/downloads/ LeitCrossBloodComponents4ed.pdf
7. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-368
8. Schöchl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastography. J Trauma 2009; 67: 125-131
9. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006; 4: 411-416
10. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-57
11. Nuttal GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 815-823
12. Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108: 734-742
13. Fenger-Eriksen C, Anke-Møller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324-329
14. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007; 105: 905-917
15. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55: 39-44
16. Niles SE, McLaughlin DF, Perkins JG. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008; 64: 1459-1465
17. Lucas CE, Ledgerwood AM. Clinical significance of altered coagulation tests after massive transfusion for trauma. Am Surg 1981; 47: 125-130
18. Eisenberg JM, Clarke JR, Sussmann SA. Prothrombin and partial thromboplastin times as perioperative screening tests. Arch Surg 1982; 117: 48-51
19. Nielsen VG. Hemodilution with lactated Ringer's solution causes hypocoagulability in rabbits. Blood Coagul Fibrinolysis 2004; 15: 55-59
20. Petroianu GA, Maleck WH, Koetter KP, Liu J, Schmitt A. Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors. Crit Care Med 2003; 31: 250-254
21. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-365
22. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003; 54: 454-463
23. Lang T, Bauters A, Braun SL, et al. Multi-centre investigations on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-310
24. De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006; 102: 1194-1200
25. Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 2009, July 17 (Epub ahead of print. Doi:10.1177/ 1076029609336855)
26. Jámbor C, Reul V, Schnider T, Degiacomi P, Metzner H, Korte W. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesth Analg 2009; 109: 1023-1028
27. Nielsen V, Kirklin J, Hoogendoorn H, Ellis T, Holman W. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis 2006; 18: 145-150
28. Chandler W, Patel M, Gravelle L, et al. Factor XIIIa and clot strength after cardiopulmonary bypass. Blood Coagul Fibrinolysis 2001; 12: 101-108
29. Wettstein P, Haeberli A, Stutz M, et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004; 99: 1564-1569
30. Westphal M, James M, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches. different products-different effects. Anesthesiology 2009; 111: 187-202
31. Scharbert G, Kozek-Langenecker S. Limitations of in-vitro experiments on hydroxyethyl starch solutions. Anesth Analg 2007; 105: 885
32. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802
33. Ruttmann T, James M, Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002; 89: 226-230
34. Ruttmann T. Haemodilution enhances coagulation. Br J Anaesth 2002; 88: 470-472
35. Ng K, Lam C, Chan L. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002; 88: 475-480